IISc-incubated Mynvax 
Dealstreet

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Bar & Bench

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Everyone talks about rights, no one speaks of duties: Justice Rajesh Bindal

Judicial independence in politically sensitive cases a mixed bag: Abhishek Manu Singhvi

Plea in Supreme Court seeks fresh probe into US govt indictment against Gautam Adani

Karnataka withdraws compulsory arbitration clause from State tenders, contracts

Bombay High Court acquits Assistant Public Prosecutor, law clerk in 22-year-old bribery case

SCROLL FOR NEXT